Financial results - BIOMAX TECHNOLOGY S.R.L.

Financial Summary - Biomax Technology S.r.l.
Unique identification code: 39671311
Registration number: J40/10674/2018
Nace: 3821
Sales - Ron
88.315
Net Profit - Ron
21.091
Employee
The most important financial indicators for the company Biomax Technology S.r.l. - Unique Identification Number 39671311: sales in 2023 was 88.315 euro, registering a net profit of 21.091 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul CAEN Ver.3: Recuperarea materialelor reciclabile; CAEN Ver.2: Tratarea si eliminarea deseurilor nepericuloase; having the NACE code 3821.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Biomax Technology S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR - - - - 64 4.907 0 34.870 160.926 88.315
Total Income - EUR - - - - 245 6.184 8.580 35.233 163.882 92.203
Total Expenses - EUR - - - - 57.236 43.469 42.803 19.252 52.186 66.654
Gross Profit/Loss - EUR - - - - -56.991 -37.285 -34.223 15.981 111.696 25.550
Net Profit/Loss - EUR - - - - -56.992 -37.340 -34.224 15.633 107.448 21.091
Employees - - - - 1 1 1 1 0 0
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales decreased by -45.0%, from 160.926 euro in the year 2022, to 88.315 euro in 2023. The Net Profit decreased by -86.031 euro, from 107.448 euro in 2022, to 21.091 in the last year.

Check the financial reports for the company - Biomax Technology S.r.l.

Rating financiar

Financial Rating -
Biomax Technology S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Biomax Technology S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biomax Technology S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Biomax Technology S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biomax Technology S.r.l. - CUI 39671311

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets - - - - 0 114 77.086 76.345 76.558 75.392
Current Assets - - - - 91.704 109.382 23.150 47.375 160.036 185.374
Inventories - - - - 89.792 88.854 12.283 12.011 10.375 12.012
Receivables - - - - 1.733 10.678 9.102 2.625 14.044 173.311
Cash - - - - 179 9.850 1.765 32.740 135.617 52
Shareholders Funds - - - - -56.347 -92.527 -124.997 -106.593 524 21.614
Social Capital - - - - 645 702 688 673 675 673
Debts - - - - 150.750 202.022 225.233 230.313 236.069 239.153
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "3821 - 3821"
CAEN Financial Year 3821
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 185.374 euro in 2023 which includes Inventories of 12.012 euro, Receivables of 173.311 euro and cash availability of 52 euro.
The company's Equity was valued at 21.614 euro, while total Liabilities amounted to 239.153 euro. Equity increased by 21.091 euro, from 524 euro in 2022, to 21.614 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Biomax Technology S.r.l.

Comments - Biomax Technology S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.